Gilead Sciences & Merck announce investigational once-weekly oral HIV treatment regimen of islatravir and lenacapavir maintained virological suppression in adults with HIV who swi ...

Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel late-stage candidates.

Ryan Timmermans, an Army veteran, invites former service-members to live away from running water and the power grid in the ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Some Québec clinics might soon use AI-powered technology to more quickly test patients for dry eye syndrome and help doctors ...

A free Providence program is helping thousands understand their breast cancer risk before symptoms ever appear An elevated ...

New York is regulating targeted pricing algorithms to ensure transparency and prevent discrimination. The 2025 APDA requires ...

King Faisal Specialist Hospital and Research Centre in Jeddah has successfully developed and implemented the world’s first protocol of its kind, using an algorithm to accurately estimate the expected ...

I want to thank you for joining NAVREF for today's discussion on the future of lung cancer screening for veterans. My name is Rashi Romanoff. I am the CEO of the National Association for Veterans ...

Introducing Nicholas Riina, MS. Nicholas Riina, MS, had his eye on the prize early on, growing up in a family in which he was ...

The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs in the controversial 340B program and equalizing payment between sites of ...

King Faisal Specialist Hospital and Research Centre in Jeddah has successfully developed and implemented the world's first protocol of ...